- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06260228
HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's) (HOBSCOTCH-PD)
The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Parkinson's Disease (PD)
The main questions it aims to answer are:
- Can the current HOBSCOTCH program be adapted for people with PD?
- Will people with PD experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program?
Participants will be asked to:
- attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-PD sessions with a one-on-one certified HOBSCOTCH-PD coach
- complete a brief clinical questionnaire about their diagnosis of PD
- complete two questionnaires before and after the HOBSCOTCH-PD sessions about their quality of life and about memory and thinking processes
- keep a short daily diary about their PD symptoms and use of the self-management strategies taught in the HOBSCOTCH-PD program
- complete a brief Satisfaction Survey after the entire HOBSCOTCH-PD program
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sarah J Kaden, MA
- Phone Number: 6035405824
- Email: sarah.j.kaden@hitchcock.org
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Recruiting
- Dartmouth-Hitchcock
-
Contact:
- Sarah J Kaden
- Phone Number: 603-540-5824
- Email: sarah.j.kaden@hitchcock.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 30 - 75 years
- Diagnosis of Parkinson's Disease per participant's provider
- Literate, English-speaking with grade 12 or equivalent in education
- Self-reported cognitive/memory difficulties
- Telephone and internet access
Exclusion Criteria:
- Cognitive dysfunction that precludes participation in giving informed consent
- Significant visual impairment precluding reading or writing
- No reliable telephone or internet access
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: PD Participant with Cognitive Dysfunction
Participants will receive the HOBSCOTCH-PD intervention consisting of 1:1 sessions delivered once per week including:
|
HOBSCOTCH is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barriers of access to care.
The program is based on Problem Solving Therapy (PST) and teaches problem solving strategies and compensatory mechanisms to help manage cognitive dysfunction and enhance quality of life.
HOBSCOTCH-PD is an adaptation of the HOBSCOTCH program for people with PD and incorporates education about Parkinson Disease and cognition into the education module.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in quality of life as measured by comparing PDQ-39 (Parkinson's Disease Questionnaire) scores pre- and post-HOBSCOTCH-PD intervention.
Time Frame: Baseline (pre-HOBSCOTCH-PD) and post-HOBSCOTCH-PD, approximately 9 weeks later.
|
The Parkinson's Disease Questionnaire (PDQ-39) is a 39-item validated, patient reported measure of quality of life.
The questionnaire assesses how often people with PD experience difficulties across 8 dimensions of daily living including relationships, social situations and communication as well as the impact of Parkinson's on specific dimensions of functioning and wellbeing.
The dimension scores are coded on a scale of 0 (perfect health as assessed by the measure) to 100 (worst health as assessed by the measure).
|
Baseline (pre-HOBSCOTCH-PD) and post-HOBSCOTCH-PD, approximately 9 weeks later.
|
Change in subjective cognition as measured by comparing Neuro-QOL Item Bank v2.0 Cognitive Function scores pre- and post-HOBSCOTCH-PD intervention.
Time Frame: Baseline (pre-HOBSCOTCH-PD) and post-HOBSCOTCH-PD, approximately 9 weeks later.
|
The Cognitive Function sub-scale of the Neuro-QOL is a brief validated tool developed by the NIH for use in patients with neurological disease.
Scores range from 8 to 40, with a higher score indicating better reported cognitive functioning.
|
Baseline (pre-HOBSCOTCH-PD) and post-HOBSCOTCH-PD, approximately 9 weeks later.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Elaine T Kiriakopoulos, MD, MPH, MSc, Dartmouth-Hitchcock, Dartmouth College
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Neurocognitive Disorders
- Parkinsonian Disorders
- Basal Ganglia Diseases
- Movement Disorders
- Synucleinopathies
- Neurodegenerative Diseases
- Cognition Disorders
- Parkinson Disease
- Cognitive Dysfunction
- Memory Disorders
Other Study ID Numbers
- STUDY02002270
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
ProgenaBiomeRecruitingParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
-
King's College LondonGlaxoSmithKlineCompletedParkinson Disease | Idiopathic Parkinson Disease | Parkinson Disease, PARK8United Kingdom
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
National Yang Ming UniversityUnknownEarly Onset Parkinson Disease | Early Stage Parkinson Disease
-
Michele Tagliati, MDRecruitingREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Cedars-Sinai Medical CenterEnrolling by invitationREM Sleep Behavior Disorder | Symptomatic Parkinson Disease | Pre-motor Parkinson DiseaseUnited States
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Parkinson' s Disease, Neurological Impairments, Tele-rehabilitationIndia
-
Merck Sharp & Dohme LLCCompletedParkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
Clinical Trials on HOme-Based Self-management and COgnitive Training CHanges lives (HOBSCOTCH)
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and PreventionRecruiting
-
Dartmouth-Hitchcock Medical CenterRecruitingMultiple Sclerosis | Cognitive Dysfunction | Memory DisordersUnited States
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and PreventionCompleted
-
Dartmouth-Hitchcock Medical CenterUnited States Department of DefenseRecruitingBrain Injuries, Traumatic | Epilepsy, TraumaticUnited States
-
Kessler FoundationNYU Langone HealthUnknownRefractory EpilepsyUnited States
-
University Hospital of North NorwayUniversity of Tromso; The Research Council of Norway; The Alfred; Aalborg University and other collaboratorsCompletedPulmonary Disease, Chronic ObstructiveNorway, Denmark, Australia
-
H. Lee Moffitt Cancer Center and Research InstituteAmerican Cancer Society, Inc.Completed
-
Federal University of Minas GeraisCompleted
-
Barts & The London NHS TrustCompletedPostoperative Cognitive DysfunctionUnited Kingdom